
Competition Commission backs Fedhealth–Medshield merger
Fedhealth’s acquisition of Medshield comes after Sanlam named Fedhealth its exclusive open medical scheme partner.

Fedhealth’s acquisition of Medshield comes after Sanlam named Fedhealth its exclusive open medical scheme partner.

The Council for Medical Schemes has advised medical schemes to limit their contribution increases for 2025 to 4.4% plus ‘reasonable’ utilisation estimates.

The Council for Medical Schemes has withdrawn a directive for Discovery to retract its communication about contribution and benefit changes for 2024.